NEW HETEROCYCLIC-CARBONYL-CYCLIC COMPOUNDS AS MAGL INHIBITORS
摘要:
The present invention provides compounds of formula (I) CB (I) or pharmaceutically acceptable salts thereof, wherein R3to R5, R4a, B and C are as described herein, compositions including the compounds, processes of manufacturing the compounds and methods of using the compounds.
NEW HETEROCYCLIC-CARBONYL-CYCLIC COMPOUNDS AS MAGL INHIBITORS
摘要:
The present invention provides compounds of formula (I) CB (I) or pharmaceutically acceptable salts thereof, wherein R3to R5, R4a, B and C are as described herein, compositions including the compounds, processes of manufacturing the compounds and methods of using the compounds.
The present invention provides compounds and compositions thereof which are useful as inhibitors of Bruton's tyrosine kinase and which exhibit desirable characteristics for the same.
The present invention provides compounds and compositions thereof which are useful as inhibitors of Bruton's tyrosine kinase and which exhibit desirable characteristics for the same.
The present invention provides compounds and compositions thereof which are useful as inhibitors of Bruton's tyrosine kinase and which exhibit desirable characteristics for the same.